Stablepoint Partners’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Stablepoint Partners’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$173K	Sell	11,262 -776	-6%	-$11.2K	0.02%	256
2026 Q1	$173K	Sell	12,038 -524	-4%	-$7.78K	0.03%	255
2025 Q4	$189K	Hold	12,562	–	–	0.03%	240
2025 Q3	$181K	Sell	12,562 -640	-5%	-$9.09K	0.03%	243
2025 Q2	$188K	Hold	13,202	–	–	0.03%	244
2025 Q1	$197K	Buy	13,202 +500	+4%	+$7.82K	0.04%	236
2024 Q4	$183K	Sell	12,702 -1,000	-7%	-$15.5K	0.03%	236
2024 Q3	$217K	Hold	13,702	–	–	0.04%	230
2024 Q2	$213K	Sell	13,702 -715	-5%	-$10.8K	0.04%	229
2024 Q1	$236K	Buy	14,417 +2,207	+18%	+$34.8K	0.05%	226
2023 Q4	$179K	Buy	+12,210	New	+$170K	0.05%	217

Other funds holding BMEZ

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Stablepoint Partners's BMEZ Position: Q2 2026 in Review

Stablepoint Partners reduced its BlackRock Health Sciences Trust II (BMEZ) stake by 6.4% in Q2 2026, selling an estimated $11.2K and leaving 11,262 shares worth $173K. The position accounts for 0.02% of the portfolio, ranked #256.

Stablepoint Partners first reported a position in BMEZ in Q4 2023 and has held it in 11 quarters since. The position peaked at $236K in Q1 2024. 89 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

Stablepoint Partners held 11,262 shares of BlackRock Health Sciences Trust II worth $173K as of Q2 2026.
Stablepoint Partners sold 776 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $11.2K.
BlackRock Health Sciences Trust II made up 0.02% of Stablepoint Partners's portfolio in Q2 2026, its #256 holding.
Stablepoint Partners first reported a position in BlackRock Health Sciences Trust II in Q4 2023 and has held it in 11 quarters since.
Stablepoint Partners's BlackRock Health Sciences Trust II position peaked at $236K in Q1 2024.
89 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Stablepoint Partners's 13F filing for Q2 2026, filed 9 Jul 2026.